$38.80
$-0.28 (-0.72%)
End-of-day quote: 05/13/2024
NasdaqGS:IONS
Ionis Pharmaceuticals Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | NasdaqGS | Outperform | $308.45 | $303.65 | 0.00% | 8 | $165.46B |
| PFE | Pfizer | NYSE | Outperform | $28.44 | $32.87 | 0.00% | 6 | $161.16B |
| SAN | Sanofi | ENXTPA | Outperform | 92.71€ | 102.80€ | 0.00% | 9 | 115.76€B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $976.96 | $961.26 | 0.00% | 8 | $105.40B |
| CSL | CSL | ASX | Outperform | $279.92 | $205.51 | 0.00% | 5 | $135.27B |
| 4568 | Daiichi Sankyo Company | TSE | Buy | ¥5.42k | ¥5.24k | 0.00% | 0 | ¥10.39T |
| MRNA | Moderna | NasdaqGS | Outperform | $125.67 | $135.42 | 0.00% | 1 | $48.16B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.10k | ¥4.74k | 0.00% | 0 | ¥6.44T |
| BIIB | Biogen | NasdaqGS | Outperform | $225.34 | $299.62 | 0.00% | 13 | $32.81B |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Outperform | $149.89 | $245.24 | 0.00% | 7 | $18.96B |
| BMRN | BioMarin Pharmaceutical | NasdaqGS | Outperform | $80.50 | $111.56 | 0.00% | 5 | $15.39B |
| SRPT | Sarepta Therapeutics | NasdaqGS | Outperform | $131.70 | $158.66 | 0.00% | 6 | $12.51B |
| INCY | Incyte | NasdaqGS | Outperform | $57.60 | $77.05 | 0.00% | 8 | $12.01B |
| JAZZ | Jazz Pharmaceuticals | NasdaqGS | Outperform | $113.17 | $188.32 | 0.00% | 4 | $7.13B |
| EXEL | Exelixis | NasdaqGS | Outperform | $21.27 | $26.44 | 0.00% | 5 | $6.34B |
| NTLA | Intellia Therapeutics | NasdaqGM | Outperform | $25.42 | $75.84 | 0.00% | 21 | $2.36B |
| DYN | Dyne Therapeutics | NasdaqGS | Buy | $26.62 | $28.13 | 0.00% | 0 | $2.27B |
| DCPH | Deciphera Pharmaceuticals | NasdaqGS | Hold | $25.42 | $23.40 | 0.00% | 4 | $2.19B |
| 4516 | Nippon Shinyaku | TSE | Outperform | ¥3.89k | ¥8.34k | 0.00% | 0 | ¥297.90B |
| BCRX | BioCryst Pharmaceuticals | NasdaqGS | Outperform | $5.63 | $14.09 | 0.00% | 2 | $1.09B |
| WVE | Wave Life Sciences | NasdaqGM | Outperform | $5.69 | $9.21 | 0.00% | 3 | $688.23M |
| PHARM | Pharming Group N.V. | ENXTAM | Buy | 0.88€ | 1.85€ | 0.00% | 2 | 591.95€M |
| STOK | Stoke Therapeutics | NasdaqGS | Buy | $11.55 | $19.33 | 0.00% | 3 | $604.59M |
| ABUS | Arbutus Biopharma | NasdaqGS | Outperform | $2.89 | $6.34 | 0.00% | 0 | $535.96M |
| KALV | KalVista Pharmaceuticals | NasdaqGM | Buy | $12.00 | $20.80 | 0.00% | 0 | $478.84M |
| FULC | Fulcrum Therapeutics | NasdaqGM | Outperform | $7.35 | $10.21 | 0.00% | 7 | $456.83M |
| PYC | PYC Therapeutics | ASX | Buy | $0.10 | $0.30 | 0.00% | 1 | $294.90M |
